Delivery Order SPE2DB22D1106-SPE2DB24FEMY1
- Not listed
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,079.76 to Amerisourcebergen Drug Corp, the Corporate Office division of major pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the provision of NARCAN 4 MG nasal spray, a critical opioid overdose treatment medication, with a period of performance through February 6, 2024. This delivery order is part of a larger single-award Indefinite Delivery...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical division awarded a Delivery Order contract valued at $1,731.44 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to reverse opioid overdoses. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication. This $5,845.27 contract has a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,443.53 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of NARCAN 4 MG NASAL SPRAY medical products. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,016,532 units of NARCAN 4 mg nasal spray. The contract, valued at $7,151.88, has a period of performance through March 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is part of a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 and with a...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,400.64 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the provision of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication. The award has an ultimate completion date of August 21, 2024. Amerisourcebergen, a large pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with...
- This contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,320,403 units of the opioid overdose reversal medication NARCAN 4 mg nasal spray to the Defense Logistics Agency (DLA) Troop Support Medical. The firm-fixed-price delivery order, valued at $1,400.64, has an ultimate completion date of August 2, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a Firm Fixed Price delivery order contract worth $2,051.89 for the supply of NARCAN 4 MG NASAL SPRAY 2S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen Drug Corp to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose treatment medication. The $1,189.68 order has a completion date of February 22, 2024. Amerisourcebergen, through its Corporate Office division in Conshohocken, Pennsylvania, holds a larger indefinite delivery contract (IDC) with DLA worth up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of NARCAN 4 MG NASAL SPRAY 2S. The contract, valued at $5,285.68, has an ultimate completion date of March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEMY1Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a $5,451.13 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide 4,564,361,379 units of the opioid overdose reversal medication NARCAN 4 mg nasal spray. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis. As a major pharmaceutical distributor, Amerisourcebergen leverages its extensive supply chain to efficiently fulfill essential medical product orders for the U.S. government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 4/22/24 |